433 W Van Buren Street
Suite 200
Chicago, IL 60607
United States
773 236 7972
https://www.wesanahealth.com
Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees:
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Daniel Carcillo | Co-Founder, CEO & Chairman | 444.2k | N/A | 1985 |
Mr. Chad Bronstein | Co-Founder | 126.35k | N/A | 1988 |
Dr. Mark A. Wingertzahn Ph.D. | Chief Scientific Officer | 402.26k | N/A | 1972 |
Mr. Zed Wang | Corporate Secretary | 207.53k | N/A | 1989 |
Mr. Keenan Gentry | Vice President of Investor Relations & Corporate Development | N/A | N/A | N/A |
Izzy Forman | Vice President of Communications | N/A | N/A | N/A |
Mr. Jeffrey T. Jewell | Senior Vice President of Medical & Scientific Affairs | N/A | N/A | N/A |
Wesana Health Holdings Inc. does not have significant operations. Previously, it was developing evidence-based formulations and protocols that empower patients to overcome neurological, psychological, and mental health ailments caused by trauma. The company is headquartered in Chicago, Illinois.
Wesana Health Holdings Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.